ABBOTT PARK, Ill. — Abbott announced today it began shipping its BinaxNOW COVID-19 Ag Self Test to retailers across the country. Consumers can expect the test to be available in the next few days online and in some stores. Broader nationwide availability is expected in the next two weeks as tests work their way through
ABBOTT PARK, Ill. — Abbott announced on Monday that the U.S. Food and Drug Administration (FDA) issued Emergency Use Authorization (EUA) for the company’s SARS-CoV-2 IgG lab-based serology blood test on the Alinity i system. Abbott plans to ship nearly 30 million antibody tests globally in May across its ARCHITECT and Alinity i platforms and
ABBOTT PARK, Ill. — Abbott announced on Friday new research, published in the Journal of Clinical Microbiology, which found that its SARS-CoV-2 IgG lab-based serology blood test had 99.9% specificity and 100% sensitivity for detecting the IgG antibody in patients 17 days or more after symptoms began. Independent research was conducted by University of Washington School of
ABBOTT PARK, Ill. — Abbott announced that the U.S. Food and Drug Administration (FDA) has issued Emergency Use Authorization (EUA) for the fastest available molecular point-of-care test for the detection of novel coronavirus (COVID-19), delivering positive results in as little as five minutes and negative results in 13 minutes. The test will run on the
ABBOTT PARK, Ill. — Abbott announced that Miles White will be stepping down as chief executive officer on March 31, 2020, after a remarkable 21-year tenure, the second longest for a non-founder in today’s S&P 100. He will remain executive chairman of the board. The board has unanimously appointed Robert Ford, a 23-year Abbott veteran, to
